Mind Medicine (MindMed) Inc.

NASDAQ:MNMD

7.32 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Revenue 0004.838000000000000000000000000000
Cost of Revenue 000.5270.790.80.8140.8050.8030.80.80.7803.2633.2631.179000000.0020.0020.00200.0070.0040.0040.006000
Gross Profit 00-0.5274.048-0.8-0.814-0.805-0.803-0.8-0.8-0.780-3.263-3.263-1.17900000-0.002-0.002-0.0020-0.007-0.004-0.004-0.006000
Gross Profit Ratio 0000.837000000000000000000000000000
Reseach & Development Expenses 17.18814.64511.17810.75613.20314.77712.5998.837.7729.32610.24134.7897.0714.6675.7598.1575.3422.71.8030.42500000000000
General & Administrative Expenses 7.6049.81310.49910.6598.41314.4078.2635.079.2117.6178.26459.06512.94128.5097.2319.0031.5412.5011.9831.05500000000000
Selling & Marketing Expenses 00000000000-0.77000.77-1.5990.6010.6860.312000000000000
SG&A 7.6049.81310.49910.6598.41314.4078.2635.079.2117.6178.26459.06512.94128.5098.0017.4042.1423.1872.2951.0550.1660.130.1250.2190.4650.240.1650.2170.4140.280.314
Other Expenses 0000.051-0.051000.0010-0.0070.036-74.6520.1520.0991.179-0.4130.138-0.03-2.1420.13800000000000
Operating Expenses 24.79224.45821.67721.41521.61629.18420.86213.916.98316.94318.50519.20223.27536.43914.93915.1487.6216.0254.2361.6170.1660.130.1250.2190.4650.240.1650.2170.4140.280.314
Operating Income -24.792-24.458-22.204-22.205-21.616-29.184-23.531-13.9-16.983-16.943-18.469-93.834-23.24-36.472-15.011-12.574-7.618-6.359-3.577-1.615-0.167-0.132-0.126-0.219-0.472-0.243-0.168-0.223-0.414-0.28-0.314
Operating Income Ratio 000-4.59000000000000000000000000000
Total Other Income Expenses Net 11.10818.604-32.196-1.6593.6930.054-3.9538.9970.498-0.0140.054-0.7010.0960.1710.1662.636-1.0540.308-3.45600-0.03600.0040.00100.003-0.2910.0030.002-0.004
Income Before Tax -13.684-5.854-54.4-23.864-17.923-29.13-24.815-4.903-16.485-16.957-18.451-94.193-23.144-36.301-14.845-12.512-8.675-5.717-7.033-1.617-0.167-0.167-0.126-0.216-0.471-0.243-0.165-0.513-0.411-0.278-0.318
Income Before Tax Ratio 000-4.933000000000000000000000000000
Income Tax Expense 000.484-1.824-0.791-0.0542.669-8.997-0.4980.0070.027-1.157-0.109-0.177-0.188-0.2261.054-0.6453.4510.00200000000000
Net Income -13.684-5.854-54.4-23.864-17.923-29.13-27.4844.094-15.987-16.957-18.478-93.036-23.144-36.301-14.845-12.512-8.675-5.717-7.033-1.617-0.167-0.167-0.126-0.216-0.471-0.243-0.165-0.513-0.411-0.278-0.318
Net Income Ratio 000-4.933000000000000000000000000000
EPS -0.18-0.081-1.14-0.59-0.45-0.76-0.720.11-0.55-0.6-0.66-3.32-0.83-1.34-0.57-0.48-0.46-0.33-0.52-0.084-0.41-0.47-0.36-0.62-1.51-0.78-0.53-1.67-1.75-1.35-2.05
EPS Diluted -0.17-0.081-1.14-0.59-0.45-0.76-0.720.11-0.55-0.6-0.66-3.32-0.83-1.33-0.57-0.48-0.46-0.33-0.52-0.084-0.41-0.47-0.36-0.62-1.51-0.78-0.53-1.67-1.75-1.35-2.05
EBITDA -12.957-5.388-53.439-23.074-21.616-28.316-24.01-13.11-16.193-16.157-17.644-28.007-16.438-33.209-13.412-12.987-7.483-5.887-3.439-1.478-0.166-0.165-0.125-0.219-0.465-0.24-0.162-0.508-0.411-0.278-0.318
EBITDA Ratio 000-4.426000000000000000000000000000